|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
3
|
Resverlogix Corp.
|
Jun 12, 2020 01:54PM
|
|
Re: Zenith a Loser Too
|
3
|
Resverlogix Corp.
|
Jun 16, 2020 08:24PM
|
|
Vietnam detects new hybrid of two COVID variants.
|
3
|
Resverlogix Corp.
|
May 29, 2021 06:28PM
|
|
Re: Last day of June.
|
3
|
Resverlogix Corp.
|
Jun 30, 2021 05:23PM
|
|
Re: Metablock
|
3
|
Resverlogix Corp.
|
Dec 06, 2021 01:13PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
3
|
Resverlogix Corp.
|
Mar 25, 2022 08:03PM
|
|
Neuropilin-1 is a host factor for SARS-CoV-2 infection.
|
3
|
Resverlogix Corp.
|
Oct 21, 2020 12:06PM
|
|
COVID-19 "competition" to keep an eye on.
|
3
|
Resverlogix Corp.
|
Feb 08, 2021 03:30AM
|
|
Re: Pfizer starting trial for oral covid therapeutic
|
3
|
Resverlogix Corp.
|
Sep 27, 2021 12:01PM
|
|
Re: "Actively Recruiting" ?
|
3
|
Resverlogix Corp.
|
Nov 08, 2021 04:52PM
|
|
A doctor's compassionate care.
|
3
|
Resverlogix Corp.
|
Nov 12, 2021 06:05PM
|
|
Report: Nearly 1 in 3 Israelis Refuse COVID-19 Treatment Pill.
|
3
|
Resverlogix Corp.
|
Jan 13, 2022 12:59PM
|
|
Re: COVID-19 "competition" to keep an eye on.
|
3
|
Resverlogix Corp.
|
Feb 09, 2021 03:33PM
|
|
Re: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study
|
3
|
Resverlogix Corp.
|
Sep 08, 2021 07:24PM
|
|
Potential new use for apabetalone?
|
3
|
Resverlogix Corp.
|
Feb 27, 2022 01:43AM
|
|
September 24th.
|
3
|
Resverlogix Corp.
|
Sep 24, 2021 03:05AM
|
|
Re: So, the mood this week was.
|
3
|
Resverlogix Corp.
|
Aug 20, 2021 08:31PM
|
|
Re: Zacks
|
3
|
Zenith Epigenetics
|
May 07, 2020 01:28PM
|
|
Re: Dec 22
|
3
|
Resverlogix Corp.
|
Nov 10, 2020 01:00PM
|
|
Re: Round one
|
3
|
Resverlogix Corp.
|
Jan 27, 2022 11:14PM
|
